Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
18 hedge funds and large institutions have $7.96M invested in Renalytix plc American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
25% more capital invested
Capital invested by funds: $6.37M → $7.96M (+$1.6M)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
9% more call options, than puts
Call options by funds: $51K | Put options by funds: $47K
14% less funds holding
Funds holding: 21 → 18 (-3)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Pinnacle Associates
New York
|
+$644K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
+$73.8K |
| 3 |
TC
Tejara Capital
London,
United Kingdom
|
+$51.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$35K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$30.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$277K |
| 2 |
Renaissance Technologies
New York
|
-$84K |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$78.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$60.7K |
| 5 |
HA
Harbor Advisors
West Palm Beach,
Florida
|
-$45K |
RNLX Hedge Fund Activity: Q1 2023 in Review
18 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q1 2023, worth a combined $7.96M — up 25% from $6.37M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RNLX and 4 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Pinnacle Associates, adding an estimated $644K. The largest seller was Pentwater Capital Management, cutting an estimated $277K.
- 18 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q1 2023, down from 21 in Q4 2022.
- Funds reported $7.96M of Renalytix plc American Depositary Shares stock for Q1 2023, up 25% quarter-over-quarter.
- 4 funds opened new Renalytix plc American Depositary Shares positions in Q1 2023 and 6 closed out, a net change of -2 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q1 2023 was Pinnacle Associates, an estimated $644K added.
- The largest Renalytix plc American Depositary Shares seller in Q1 2023 was Pentwater Capital Management, an estimated $277K sold.
Based on aggregated 13F filings for Q1 2023.